We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Handheld Lab to Enable Faster, Cheaper Point-of-Need Bacterial Infection Identification

By LabMedica International staff writers
Posted on 30 Nov 2022
Print article
Image: Portable, handheld reader, with cloud-based ML algorithms to identify bacterial species within five minutes (Photo courtesy of Nostics)
Image: Portable, handheld reader, with cloud-based ML algorithms to identify bacterial species within five minutes (Photo courtesy of Nostics)

Antimicrobial resistance (AMR) is the unresponsiveness of bacteria to a certain antibiotic due to mutations or resistance genes the species has gained. This is a natural process, however, with the copious amounts of antibiotics that are used, this process is highly accelerated and becomes a danger to our healthcare system. For most people, treatment for bacterial infections is based merely on symptoms, which increases the chance of misdiagnosis and prolonged disease course. Now, instant, accessible, reliable testing for viruses and bacteria will be soon made possible by the world’s smallest portable bacteria identification lab that uses cloud-based, machine learning algorithms to identify bacterial species in five minutes, without the need for expert users or expensive lab infrastructure.

Nostics B.V. (Amsterdam, The Netherlands) is taking spectroscopy where it has never been before: bacterial identification. By combining spectroscopy with nanotechnology and advanced AI classification, the company will soon launch a novel diagnostic tool for point-of-care (PoC) bacterial infection identification. The new digital diagnostics platform from Nostics can provide fast and accurate diagnostics for bacterial infections without the need for costly labs.

The Nostics PoC solution can fit in a backpack, making diagnostics accessible which is the key to combating AMR. By using a handheld device, Raman spectroscopy, cutting-edge nanosurfaces and advanced AI algorithms, the platform has the potential to change the lives of people in places without access to bacterial diagnostics and accelerate this access in countries with more developed healthcare facilities.

Related Links:
Nostics B.V.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.